C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 409/04 (2006.01) A61K 31/404 (2006.01) A61K 31/5377 (2006.01) C07D 409/14 (2006.01) C07D 413/14 (2006.01)
Patent
CA 2681821
The invention is directed to novel indole carboxamide compounds. Specifically, the invention is directed to compounds according to formula (I): wherein R1, R2, R3, R4, and m are as defined herein. The compounds of the invention are inhibitors of IKK2 and can be useful in the treatment of disorders associated with inappropriate IKK2 (also known as IKK.beta.) activity, such as rheumatoid arthritis, asthma, rhinitis, and COPD (chronic obstructive pulmonary disease). Accordingly, the invention is further directed to pharmaceutical compositions comprising a compound of the invention. The invention is still further directed to methods of inhibiting IKK2 activity and treatment of disorders associated therewith using a compound of the invention or a pharmaceutical composition comprising a compound of the invention.
L'invention concerne de nouveaux composés d'indole carboxamide. L'invention concerne spécifiquement des composés de formule (I) : dans laquelle R1, R2, R3, R4 et m sont tels que définis dans le présent document. Les composés selon l'invention sont des inhibiteurs d'IKK2 et peuvent être utiles dans le traitement de troubles associés avec une activité inappropriée d'IKK2 (également connu sous le nom d'IKK.beta.), par exemple la polyarthrite rhumatoïde, l'asthme, la rhinite et la BPCO (bronchopneumopathie chronique obstructive). L'invention concerne également des compositions pharmaceutiques qui comprennent un composé selon l'invention. L'invention concerne également des procédés d'inhibition de l'activité d'IKK2 et de traitement de troubles associés avec l'activité d'IKK2 qui utilisent un composé selon l'invention ou une composition pharmaceutique qui comprend un composé selon l'invention.
Boehm Jeffrey Charles
Busch-Petersen Jakob
Fu Wei
Jin Qi
Kerns Jeffrey K.
Glaxosmithkline Llc
Gowling Lafleur Henderson Llp
Smithkline Beecham Corporation
LandOfFree
Indole carboxamides as ikk2 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Indole carboxamides as ikk2 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indole carboxamides as ikk2 inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1988112